Adsorption and co-adsorption of ethylene, acetylene and hydrogen on Pd-Ag particles, supported on thin alumina films, have been studied by temperature programmed desorption (TPD). The TPD results show that adding of Ag to Pd suppresses overall hydrogenat ion activity but increases selectivity towards ethylene, i.e. similar to that observed on real catalysts. The results are rationalized on the basis of a complex interplay between surface and subsurface hydrogen species available in the system, whereby the latter species are the most critical for total hydrogenation of acetylene to ethane.
The reactions of hydrogen, ethylene, and cyclohexene have been investigated on Co/Pt(111) surfaces using temperature-programmed desorption (TPD). When Co is deposited on Pt(111) at 0.5-1 ML (monolayer) Co coverage, hydrogen desorption occurs in the temperature range of 150-250 K, which is significantly lower in temperature than from pure Pt(111) or a thick Co film on Pt(111). The ethylene decomposition reaction pathway is also significantly decreased on the 0.5-1 ML Co/Pt(111) surfaces. In addition, cyclohexene reaction pathways on 1 ML Co/Pt( 111) are different from pure Pt(111) or thick Co films. The only reaction pathways of cyclohexene on Pt(111) or thick Co films are dehydrogenation to benzene and complete decomposition. However, on the ∼1 ML Co/Pt(111) surface, a new hydrogenation reaction pathway to cyclohexane is present at 221 K. These reactions on the Co/Pt(111) surfaces are further compared to our earlier studies of the Ni/ Pt(111) surfaces. The novel activity of the 1 ML Co/Pt(111) surface is explained by the modification of the Pt d-band center by the subsurface Co atoms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.